Ustekinumab in Hidradenitis Suppurativa: A Systematic Review and Meta-analysis

• मुख्य लेखकों: Rahul Masson (लेखक), Justine Seivright (लेखक), Tristan Grogan (लेखक), Swetha Atluri (लेखक), Iltefat Hamzavi (लेखक), Marcia Hogeling (लेखक), Vivian Y. Shi (लेखक), Jennifer L. Hsiao (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Adis, Springer Healthcare, 2024-06-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Introduction Hidradenitis suppurativa (HS) is a frequently debilitating, inflammatory skin condition. Patients may have a limited response to adalimumab, currently the only Food and Drug Administration (FDA)-approved biologic treatment for HS. Ustekinumab is an interleukin-12/23 inhibitor t...